Public disclosures

Schaeffer Orlov S Nicole

Company insiders · Chief People Strategy Officer · INSMED Inc

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-20.Following & alerts
Reported transaction lines
7
Buy lines
0
Sell lines
3

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-117

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Exercise or conversion
Filing details

SEC transaction code M

Stock Option (right to buy) · Derivative security · Direct ownership · Reported balance after transaction: 0 · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

2026-11-192026-11-20

45,700 shares/units

SEC 4
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Exercise or conversion
Filing details

SEC transaction code M

Stock Option (right to buy) · Derivative security · Direct ownership · Reported balance after transaction: 0 · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

2026-11-192026-11-20

55,400 shares/units

SEC 4
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 41895 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · This is the weighted average sales price representing 2,262 shares sold at prices ranging from $147.38 to $148.01 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

2026-11-192026-11-20

≈ $333,645.00

2,262 shares/units

SEC 4
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 44157 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · This is the weighted average sales price representing 8,539 shares sold at prices ranging from $146.10 to $147.09 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

2026-11-192026-11-20

≈ $1,253,183.64

8,539 shares/units

SEC 4
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 52696 · SEC code covers open-market or private transactions · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · This is the weighted average sales price representing 90,299 shares sold at prices ranging from $145.00 to $145.93 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

2026-11-192026-11-20

≈ $13,098,772.94

90,299 shares/units

SEC 4
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Exercise or conversion
Filing details

SEC transaction code M

Common Stock · Direct ownership · Reported balance after transaction: 142995 · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

2026-11-192026-11-20

45,700 shares/units

SEC 4
Schaeffer Orlov S Nicole

Chief People Strategy Officer · INSMED Inc

INSM

INSMED Inc

Exercise or conversion
Filing details

SEC transaction code M

Common Stock · Direct ownership · Reported balance after transaction: 97295 · This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. · Includes 141 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

2026-11-192026-11-20

55,400 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement